BFC Planning’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
Other funds holding XERS
BFC Planning's XERS Position: Q3 2026 in Review
BFC Planning opened a new position in Xeris Biopharma Holdings (XERS) in Q3 2026: 1,000 shares worth $9.6K. The stake represents ﹤0.01% of the portfolio and ranks #2408 among its holdings.
185 funds tracked by Wall St. Rank hold XERS as of Q3 2026.
- BFC Planning held 1,000 shares of Xeris Biopharma Holdings worth $9.6K as of Q3 2026.
- Xeris Biopharma Holdings was a new BFC Planning position in Q3 2026.
- Xeris Biopharma Holdings made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2408 holding.
- 185 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.